Logo for Relay Therapeutics Inc

Relay Therapeutics Investor Relations Material

Latest events

Logo for Relay Therapeutics Inc

Study Update

Relay Therapeutics
Logo for Relay Therapeutics

Q4 2023

22 Feb, 2024
Logo for Relay Therapeutics

Q3 2023

2 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Relay Therapeutics Inc

Access all reports
Relay Therapeutics Inc. is a clinical-stage precision medicine company focusing on the development of small molecule therapeutics. The company operates at the intersection of computational and experimental technologies to enhance drug discovery, particularly in the areas of targeted oncology and genetic diseases. Relay Therapeutics utilizes its proprietary Dynamo platform to address previously intractable or inadequately drugged protein targets by leveraging insights into protein motion and function. This platform integrates various cutting-edge computational and experimental methods to facilitate the drug discovery process. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.